Details of the National Institutes of Health-funded study were published this week in a Nature paper titled A brain reward circuit inhibited by next-generation weight-loss drugs in mice. In it, the team reported that they investigated the small-molecule GLP-1s including Eli Lillys recently approved drug orforglipron, also known by the brand name Foundayo, as well as danuglipron, an oral GLP-1 that was being developed by Pfizer until the company decided to discontinue its development in 2025
N-Acetyl Selank Amidate carries end-chain modifications that raise stability and bioavailability
Weight loss and body contouring Rapid weight loss from Ozempic , Mounjaro , or (in future) retatrutide can leave loose skin or stubborn fat
Unlike traditional treatments that often just mask pain, peptides work with your body's natural healing processes to create lasting solutions for injuries from persistent tendon problems to stubborn joint pain
When food sits in the stomach longer and stomach acid production decreases, the body ability to extract vitamin B12 from dietary sources drops significantly
Beyond these medical applications, IV treatments, such as vitamin-based therapies, are used as part of overall wellness routines or to correct imbalances in the body, such as iron deficiency, and treat various skin diseases